» Articles » PMID: 17095875

Lifestyle Factors and Multiple Sclerosis: A Case-control Study in Belgrade

Overview
Specialties Neurology
Public Health
Date 2006 Nov 11
PMID 17095875
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this case-control study was to assess the risk of developing multiple sclerosis (MS) associated with certain lifestyle factors (cigarette smoking and coffee and alcohol consumption). The study groups consisted of 210 cases with clinically proven and/or laboratory-confirmed MS (Poser's criteria) and an identical number of sex- and age-matched hospital controls. In the MS patients, cigarette smoking was significantly more frequent than in the controls (OR = 1.6, p = 0.021). A dose-response relationship between the risk of MS and both duration (years) of smoking (p = 0.027) and number of cigarettes smoked daily (p = 0.021) was observed. Coffee consumption was significantly more frequent in the MS group (OR = 1.7, p = 0.047), with dose-response relationships. The analysis of alcohol drinking showed a significant association between consumption of hard liquor per day and risk of MS (OR = 6.7, p = 0.026). In multivariate logistic regression analysis, smoking was detected to be a significant independent risk factor for MS (OR = 2.4, p = 0.004).

Citing Articles

Alcohol Consumption and Autoimmune Diseases.

Terracina S, Caronti B, Lucarelli M, Francati S, Piccioni M, Tarani L Int J Mol Sci. 2025; 26(2).

PMID: 39859557 PMC: 11766456. DOI: 10.3390/ijms26020845.


The Effects of Coffee/Caffeine in Patients with Multiple Sclerosis; A Systematic Review.

Salekzamani S, Baharomid S, Pakkhesal S, Balafkandeh M, Gholipour-Khalili E, Talebi M J Evid Based Integr Med. 2024; 29:2515690X241293114.

PMID: 39460478 PMC: 11514122. DOI: 10.1177/2515690X241293114.


Impact of Alcohol Consumption on Multiple Sclerosis Using Model-based Standardization and Misclassification Adjustment Via Probabilistic Bias Analysis.

Malekifar P, Nedjat S, Abdollahpour I, Nazemipour M, Malekifar S, Mansournia M Arch Iran Med. 2024; 26(10):567-574.

PMID: 38310413 PMC: 10862089. DOI: 10.34172/aim.2023.83.


The Importance of Managing Modifiable Comorbidities in People with Multiple Sclerosis: A Narrative Review.

Nociti V, Romozzi M J Pers Med. 2023; 13(11).

PMID: 38003839 PMC: 10672087. DOI: 10.3390/jpm13111524.


A case-control study of drinking beverages and the risk of multiple sclerosis in Iran.

Dastoorpoor M, Nabavi S, Majdinasab N, Javid A, Angali K, Seyedtabib M J Health Popul Nutr. 2023; 42(1):22.

PMID: 36959679 PMC: 10037787. DOI: 10.1186/s41043-023-00364-8.